Casdin Capital, LLC - Significant Ownership

Signature - Title
Steve Giordano - General Counsel
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Casdin Capital, LLC.

Significant Ownership of Casdin Capital, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LAB STANDARD BIOTOOLS INC. Common Stock, par value $0.001 per share 21.6% $83.7M 80.9M Eli Casdin Feb 28, 2025
BLFS BioLife Solutions, Inc. Common Stock, $0.001 par value 18.5% $229M 8.74M Casdin Capital, LLC Apr 7, 2025
NGNE Neurogene Inc. Common Stock, $0.000001 par value 8.7% $21.8M 1.3M Casdin Capital, LLC Dec 31, 2024
TNYA Tenaya Therapeutics, Inc. Common Stock, $0.0001 par value per share 4.3% $4.51M 6.73M Casdin Capital, LLC Mar 4, 2025

Schedules 13D/G Reported by Casdin Capital, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.